Delayed-type hypersensitivity, in vitro T-cell responsiveness and risk of active coccidioidomycosis among HIV-infected patients living in the coccidioidal endemic area

References

• Birx DL, Brundage J, Larson K, et al. The prognostic utility of delayed-type hypersensitivity skin testing in the evaluation of HIV-infected patients. Military Medical Consortium for Applied Retroviral Research. J Acquired Immun Defic Syndr 1993; 6: 1248–1257.
   Google Scholar
• Gordin FM, Hartigan PM, Klimas NG, et al. Delayed type hypersensitivity skin tests are an independent predictor of hu-man immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study Group. J Infect Dis 1994; 169: 893–897.
   PubMedGoogle Scholar
• Roos MTL, Miedema F, Koot M, et al. T cell function in vitro is an independent progression marker for AIDS in hu-man immunodeficiency virus-infected asymptomatic subjects. J Infect Dis 1995; 171: 531–536.
   PubMedGoogle Scholar
• Dolan MJ, Clerici M, Blatt SP, et al. In vitro T cell function, delayed-type hypersensitivity skin testing and CD4T cellsubset phenotyping independently predict survival time in pa-tients infected with human immunodeficiency virus. J Infect Dis 1995; 172: 79–87.
   PubMed Web of Science ®Google Scholar
• Fish DG, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore) 1990; 69: 384–391.
   PubMed Web of Science ®Google Scholar
• Jones JL, Fleming PL, Ciesielski CA, et al. Coccidioidomyco-sis among persons with AIDS in the United States. J Infect Dis 1995; 171: 961–966.
   PubMed Web of Science ®Google Scholar
• Singh VR, Smith DK, Lawrence J, et al. Coccidioidomycosis in patients infected with human immunodeficiency virus: re-view of 91 cases at a single institution. Clin Infect Dis 1996; 23: 563–568.
   PubMed Web of Science ®Google Scholar
• Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis dur-ing human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med 1993; 94: 235–240.
   Google Scholar
• Lee ET. Statistical Methods for Survival Data Analysis, 2nd edn. New York, NY: John Wiley & Sons Inc., 1992.
   Google Scholar
• Centers for Disease Control and Prevention. Revision of the CDC surveillance case definition for acquired immunodefi-ciency syndrome. M orb Mortal Wkly Rep 1987; 36: 1S–14S.
   Google Scholar
• Ampel NM, Bejarano GC, Salas SD, Galgiani JN. In vitro assessment of cellular immunity in human coccidioidomycosis: relationship between dermal hypersensitivity, lymphocyte transformation, and lymphokine production by peripheral blood mononuclear cells from healthy adults. J Infect Dis 1992; 165: 710–715.
   PubMedGoogle Scholar
• Sokal RR, Rohlf FJ. Biometry. The Principles and Practice of Statistics in Biological Research. New York, NY: W. H. Free-man and Company, 1995.
   Google Scholar
• Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 in-fection. Ann Intern Med 1997; 126: 946–954.
   PubMed Web of Science ®Google Scholar
• Cooper DA, Emery S. Therapeutic strategies for HIV infec-tion—time to think hard (editorial). New Engl J Med 1998; 339: 1319–1321.
   PubMedGoogle Scholar
• Apolonio EG, Hoover DR, He Y, et al. Prognostic factors in human immunodeficiency virus-positive patients with a CD4 ± lymphocyte count 50M. J Infect Dis 1995; 171: 829–836.
   PubMedGoogle Scholar
• Graham NMH, Park LP, Piantadosi S, et al. Prognostic value of combined response markers among human im-munodeficiency virus-infected persons: aid in the decision to change zidovudine monotherapy. Clin Infect Dis 1995; 20: 352–362.
   PubMedGoogle Scholar
• Blatt SP, Hendrix CW, Butzin CA, et al. Delayed-type hyper-sensitivity skin testing predicts progression to AIDS in HIV-infected patients. Ann Intern Med 1993; 119: 177–184.
   PubMed Web of Science ®Google Scholar
• Markowitz N, Hansen NI, Wilcosky TC, et al. Tuberculin and energy testing in HIV-seropositive and HIV-seronegative persons. Ann Intern Med 1993; 119: 185–193.
   PubMedGoogle Scholar
• Moreno S, Baraia-Etxaburu J, Bouza E, et al. Risk for devel-oping tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993; 119: 194–198.
   PubMedGoogle Scholar